| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J3490 |
Unclassified drugs |
10,711 |
3,979 |
$1.30M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
20,554 |
6,244 |
$260K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,343 |
1,266 |
$74K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
353 |
343 |
$65K |
| 36415 |
Collection of venous blood by venipuncture |
639 |
536 |
$40K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
879 |
816 |
$37K |
| 87081 |
|
529 |
519 |
$35K |
| A9270 |
Non-covered item or service |
3,631 |
381 |
$25K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,341 |
105 |
$13K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
569 |
561 |
$11K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
139 |
137 |
$9K |
| 80053 |
Comprehensive metabolic panel |
239 |
221 |
$8K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
172 |
164 |
$7K |
| G0008 |
Administration of influenza virus vaccine |
747 |
116 |
$6K |
| 87631 |
|
46 |
45 |
$5K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
44 |
41 |
$974.65 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
625 |
614 |
$852.88 |
| 0124A |
|
237 |
32 |
$784.93 |
| 71045 |
Radiologic examination, chest; single view |
14 |
13 |
$510.01 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
447 |
402 |
$182.51 |
| 87210 |
|
17 |
13 |
$155.28 |
| Q3014 |
Telehealth originating site facility fee |
14 |
13 |
$69.29 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
18 |
16 |
$0.01 |
| 90662 |
|
43 |
40 |
$0.00 |
| 83605 |
|
13 |
13 |
$0.00 |
| 90686 |
|
28 |
27 |
$0.00 |
| 83735 |
|
16 |
15 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
13 |
12 |
$0.00 |